Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

FRESENIUS SE & CO. KGAA

(FRE)
  Report
Delayed Xetra  -  11:35:09 2023-02-03 am EST
27.11 EUR   -0.44%
02/03Despite criticism: many corporations stick to online AGMs
DP
02/02European Midday Briefing: Stocks Buoyed by Fed's Tightening Slowdown
DJ
02/02FRESENIUS SE : Receives a Buy rating from Jefferies
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Helen Giza is the new CEO of Fresenius Medical Care; Dr. Carla Kriwet leaves the company

12/05/2022 | 05:43pm EST

EQS-Ad-hoc: Fresenius SE & Co. KGaA / Key word(s): Personnel
Helen Giza is the new CEO of Fresenius Medical Care; Dr. Carla Kriwet leaves the company

05-Dec-2022 / 23:40 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Helen Giza is the new CEO of Fresenius Medical Care; Dr. Carla Kriwet leaves the company

Today, the Supervisory Board of Fresenius Medical Care Management AG, the General Partner of Fresenius Medical Care AG & Co. KGaA, has unanimously appointed Helen Giza as CEO of the Management Board with effect as of 6 December 2022. Helen Giza continues to serve as Chief Financial Officer of Fresenius Medical Care until further notice. Her predecessor, Dr. Carla Kriwet is leaving the company at her own request and by mutual agreement due to strategic differences.

As CEO of Fresenius Medical Care, Helen Giza will also join the Management Board of Fresenius Management SE. Dr. Carla Kriwet will leave the Management Board of Fresenius Management SE.

Fresenius SE & Co. KGaA, 
represented by Fresenius Management SE, 
The Management Board

Bad Homburg v.d.H., December 5, 2022

----------------------------------------
Contact:
Markus Georgi
Senior Vice President Investor Relations & Sustainability
T: +49 (0) 6172 608-2485
markus.georgi@fresenius.com
----------------------------------------

End of Note
 

05-Dec-2022 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Fresenius SE & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg v.d.H.
Germany
Phone: +49 (0)6172 608-2485
Fax: +49 (0)6172 608-2488
E-mail: ir-fre@fresenius.com
Internet: www.fresenius.com
ISIN: DE0005785604
WKN: 578560
Indices: DAX
Listed: Regulated Market in Dusseldorf, Frankfurt (Prime Standard), Munich; Regulated Unofficial Market in Berlin, Hamburg, Hanover, Stuttgart, Tradegate Exchange; Luxembourg Stock Exchange
EQS News ID: 1505587

 
End of Announcement EQS News Service

1505587  05-Dec-2022 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1505587&application_name=news&site_id=zonebourse_sftp

ę EQS 2022
All news about FRESENIUS SE & CO. KGAA
02/03Despite criticism: many corporations stick to online AGMs
DP
02/02European Midday Briefing: Stocks Buoyed by Fed's Tightening Slo..
DJ
02/02FRESENIUS SE : Receives a Buy rating from Jefferies
MD
02/02Formycon Licenses Stelara Biosimilar Candidate to Fresenius Unit
MT
01/31FRESENIUS SE : Warburg Research sticks Neutral
MD
01/30FRESENIUS SE : Barclays gives a Buy rating
MD
01/29GMK chairman: distance to hospital not decisive
DP
01/27European Equities Move Lower Friday, Set to End Week in Negative Territory
MT
01/27FRESENIUS SE : JP Morgan reaffirms its Neutral rating
MD
01/25FRESENIUS SE : Barclays reiterates its Buy rating
MD
More news
Analyst Recommendations on FRESENIUS SE & CO. KGAA
More recommendations
Financials
Sales 2022 40 920 M 44 406 M 44 406 M
Net income 2022 1 608 M 1 745 M 1 745 M
Net Debt 2022 23 184 M 25 159 M 25 159 M
P/E ratio 2022 9,56x
Yield 2022 3,03%
Capitalization 15 269 M 16 570 M 16 570 M
EV / Sales 2022 0,94x
EV / Sales 2023 0,88x
Nbr of Employees 319 691
Free-Float 73,0%
Chart FRESENIUS SE & CO. KGAA
Duration : Period :
Fresenius SE & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS SE & CO. KGAA
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Last Close Price 27,11 €
Average target price 35,53 €
Spread / Average Target 31,1%
EPS Revisions
Managers and Directors
Michael Sen Chief Executive Officer
Sara Hennicken Chief Financial Officer
Wolfgang Kirsch Chairman-Supervisory Board
Michael Albrecht Independent Member-Supervisory Board
Konrad K÷lbl Member-Supervisory Board
Sector and Competitors